Muscular dystrophies are a group of progressive muscular diseases characterized by muscular atrophy, each with a distinct pattern of muscle weakness, onset, and severity. Dysferlinopathies, including limb‐girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi Myopathy, result from a loss of dysferlin, a membrane‐associated protein shown to mediate calcium‐dependent sarcolemma repair, vesicle trafficking, and cell adhesion (Bansal et al. This evidence concerns the gene DYSF and muscular dystrophy.